Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
S. E. de Boer*, J. S.F. Sanders, F. J. Bemelman, M. G.H. Betjes, J. G.M. Burgerhof, L. Hilbrands, D. Kuypers, B. C. van Munster, S. A. Nurmohamed, A. P.J. de Vries, A. D. van Zuilen, D. A. Hesselink, S. P. Berger
Research output: Contribution to journal › Article › Academic › peer-review
9Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients'. Together they form a unique fingerprint.